Circulating bioactive sclerostin levels in an Austrian population-based cohort.

Katharina Kerschan-SchindlUrsula Föger-SamwaldAndreas GleissStefan KudlacekJacqueline WallwitzPeter Pietschmann

Published in: Wiener klinische Wochenschrift (2021)

Using the ELISA detecting bioactive sclerostin our results are consistent with data in the literature obtained by different sclerostin assays. The determination of sclerostin concentrations in peripheral blood thus appears to be a robust parameter of bone metabolism.

Keyphrases

peripheral blood
systematic review
bone mineral density
high throughput
big data
mass spectrometry
artificial intelligence
data analysis